| Issue |
Med Sci (Paris)
Volume 37, Number 4, Avril 2021
Nos jeunes pousses ont du talent !
|
|
|---|---|---|
| Page(s) | 406 - 408 | |
| Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
| DOI | https://doi.org/10.1051/medsci/2021043 | |
| Published online | 28 April 2021 | |
Le rituximab dans le traitement du lymphome diffus à grandes cellules B
L’expression de la sous-unité CACNA1C du canal Cav 1.2 liée à certaines formes de résistance
Rituximab in the treatment of diffuse large B-cell lymphoma: The CACNA1C subunit of channel Cav1.2 expression linked to certain forms of resistance
1
M1 Biologie Santé, Université Paris-Saclay, 91405 Orsay, France.
2
Inserm U1193 Physiopathologie et traitement des maladies du foie, Université Paris-Saclay, France.
a sonia.bouabdallah@universite-paris-saclay.fr
b jeremy.besson@universite-paris-saclay.fr
c mohamed.mariko@universite-paris-saclay.fr
d olivier.dellis@université-paris-saclay.fr
Cet article ne possède pas de résumé.
© 2021 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
